Recent advances of nanocrystals in cancer theranostics

Devyani Yenurkar1, Malay Nayak1, Sudip Mukherjee1

  • 1School of Biomedical Engineering, Indian Institute of Technology, BHU Varanasi-221005 UP India sudip.bme@iitbhu.ac.in.

Nanoscale Advances
|August 10, 2023
PubMed

Insights

Nanocrystals (NCs) offer a promising solution for cancer theranostics, enabling efficient drug delivery and advanced diagnostics. This review explores NCs

Area of Science:

  • Nanomedicine and Cancer Theranostics

Background:

  • Conventional cancer therapies face limitations in efficacy and drug delivery.
  • There is a growing need for advanced diagnostic and therapeutic strategies for cancer management.

Purpose of the Study:

  • To review the diverse applications of Nanocrystals (NCs) in cancer theranostics.
  • To summarize NC-based therapies, imaging, diagnostics, and their limitations.
  • To discuss the current status and future prospects of NCs in oncology.

Main Methods:

  • Comprehensive literature review of Nanocrystal applications in cancer research.
  • Analysis of various therapeutic modalities utilizing Nanocrystals.
  • Examination of Nanocrystal-based imaging and diagnostic techniques.
  • Discussion of preclinical and clinical data on Nanocrystal efficacy and safety.

Main Results:

  • Nanocrystals facilitate the delivery of poorly water-soluble drugs with sustained release and low toxicity.
  • NCs are versatile in various cancer therapies including anticancer, immunotherapy, radiotherapy, and photothermal/photodynamic treatments.
  • NCs enable advanced diagnostics through MRI, CT, biosensing, and luminescence imaging.
  • Preclinical and clinical data highlight the significant role of NCs in cancer diagnosis and treatment.

Conclusions:

  • Nanocrystals represent a significant advancement in cancer theranostics, offering improved drug delivery and diagnostic capabilities.
  • Addressing the limitations of NCs is crucial for their broader clinical implementation.
  • NCs hold substantial promise for the future of personalized cancer care and management.